Why the study?
Is raised CMR-derived LVFP associated with symptoms, signs, and adverse prognosis (HF hospitalization and MACE) in patients with heart failure?
Is raised CMR-derived LVFP associated with symptoms, signs, and adverse prognosis (HF hospitalization and MACE) in patients with heart failure?
CMR-derived left ventricular filling pressure serves as a non-invasive prognostic marker for symptoms, heart failure hospitalizations, and MACE in heart failure patients.
Raised CMR-derived LVFP is strongly associated with symptoms and signs of HF. In addition, raised CMR-derived LVFP is independently associated with subsequent HF hospitalization and MACE.
No takes yet. Share an insight, caveat, or question.
Grafton‐Clarke et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: